| 摘要 |
<p>MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER5The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon10 cancer, hepatic cancer, head-neck cancer, cancer of the gallbladder, and the metastases thereof.Figure for publication: None</p> |
